In a patient with pneumonia who develops sepsis, septic shock, or systemic inflammatory response syndrome (SIRS), which hemodynamic change is most likely observed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Hemodynamic Changes in Sepsis/Septic Shock

In a patient with pneumonia who develops sepsis or septic shock, the most likely hemodynamic change is increased cardiac output (Option A), characterized by a hyperdynamic state with elevated cardiac output and decreased systemic vascular resistance—the hallmark of distributive shock.

Understanding the Hemodynamic Profile

Sepsis and septic shock are fundamentally characterized by distributive hypovolemia, vasoplegia (decreased systemic vascular resistance), and myocardial depression 1. The key pathophysiologic feature is vasoplegia—a profound decrease in systemic vascular resistance that drives the clinical picture.

The Classic Hyperdynamic Pattern

The typical hemodynamic profile in septic shock includes:

  • Increased cardiac output: The heart compensates for the profound vasodilation by increasing cardiac output, often to supranormal levels 2
  • Decreased systemic vascular resistance (SVR): This is the defining feature—not increased SVR as suggested in option C 1, 3
  • Variable central venous pressure: CVP is not characteristically elevated and depends on volume status and right ventricular function 1

Early sepsis presents with warm, vasodilated peripheries, bounding pulses, and a hyperdynamic circulation 3. This "warm shock" pattern with high cardiac index and low SVR is particularly common, occurring in 94% of fluid-resistant septic shock cases in certain populations 4.

Temporal Evolution and Clinical Nuances

Early vs. Late Sepsis

The hemodynamic picture evolves over time:

  • Early/hyperdynamic phase: Increased cardiac output, decreased SVR, warm peripheries, fever, tachycardia 3, 5
  • Late/hypodynamic phase: If untreated or in advanced disease, cardiac output may eventually decrease due to progressive myocardial dysfunction, hypovolemia, and metabolic derangements 3, 5

However, at presentation to medical care with septic shock, the hyperdynamic state predominates 2. The low-output state typically represents either very late/terminal sepsis or inadequate fluid resuscitation 3.

Important Caveats

Community-acquired sepsis (like pneumonia) may show more heterogeneity: While catheter-associated infections almost universally present with high cardiac output/low SVR (94%), community-acquired sepsis shows this pattern in only 14% of cases initially, with many presenting with normal or low cardiac index 4. However, this reflects early, fluid-resistant shock before adequate resuscitation—not the established septic shock state.

After appropriate fluid resuscitation (minimum 30 mL/kg crystalloids per guidelines 6), the characteristic hyperdynamic pattern with increased cardiac output emerges as the dominant hemodynamic profile 7, 6.

Why the Other Options Are Incorrect

Option B: Increased Central Venous Pressure

CVP is not characteristically elevated in septic shock. In fact, distributive hypovolemia (fluid shifts from intravascular to extravascular space) often leads to decreased preload 1. CVP may be low, normal, or elevated depending on:

  • Volume resuscitation status
  • Right ventricular function
  • Presence of pulmonary hypertension or ARDS

Option C: Increased Systemic Vascular Resistance

This is fundamentally incorrect. Septic shock is defined by vasoplegia—profoundly decreased SVR 1, 3, 2. The low SVR is what necessitates vasopressor therapy (norepinephrine as first-line) to restore adequate perfusion pressure 7, 6.

Increased SVR would suggest:

  • Cardiogenic shock
  • Hypovolemic shock
  • Obstructive shock
  • Not septic/distributive shock

Clinical Application

When managing pneumonia-associated septic shock:

  1. Expect hyperdynamic circulation: High cardiac output with low SVR after adequate fluid resuscitation
  2. Fluid resuscitate aggressively: Minimum 30 mL/kg crystalloids initially 6
  3. Use norepinephrine for persistent hypotension: To counteract the low SVR 7, 6
  4. Monitor for myocardial dysfunction: While cardiac output is typically elevated, sepsis-induced myocardial depression can coexist 1
  5. Consider right ventricular failure: Especially in pneumonia with ARDS, where pulmonary hypertension may complicate the picture 1

The answer is definitively A: Increased cardiac output, reflecting the distributive, hyperdynamic nature of septic shock with compensatory elevation in cardiac output attempting to maintain tissue perfusion despite profound vasodilation.

References

2
Research

Septic shock.

The American journal of the medical sciences, 1991

5
Research

[Hemodynamics during septic shock].

Schweizerische medizinische Wochenschrift, 1980

Related Questions

Is the systemic inflammatory response syndrome (SIRS) no longer required to diagnose sepsis?
What is the definition of sepsis?
What are the early manifestations of septic shock?
What laboratory tests should be ordered to evaluate suspected Chronic Inflammatory Response Syndrome (CIRS)?
What are the criteria for the Centers for Medicare and Medicaid Services (CMS) sepsis bundle?
When should a patient with rhabdomyolysis be admitted to the hospital?
In patients with atopic dermatitis, when and how should allergen-specific immunotherapy be considered?
What are the indications, dosing regimens, contraindications, and monitoring requirements for denosumab (a fully human monoclonal antibody against RANK ligand)?
Should a 60-year-old asthmatic female with fever, nonproductive cough, dyspnea, bibasal crackles and wheezes who refuses admission be evaluated for pneumonia and managed as an outpatient?
In a patient receiving amikacin for non‑tuberculous mycobacterial infection, should therapeutic drug monitoring include both peak and trough levels, or is a trough level alone sufficient?
If serum creatinine has risen slightly but remains stable, can I rely on a trough level alone for amikacin monitoring?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.